Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines

@inproceedings{Wright2017AustralasianSF,
  title={Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines},
  author={Edwina J. Wright and Andrew Edwin Grulich and Katy Roy and M. Boyd and Vincent J Cornelisse and Darren Russell and Darryl O'Donnell and Bill Whittaker and Levinia Crooks and Iryna B Zablotska},
  booktitle={Journal of virus eradication},
  year={2017}
}
Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine's (ASHM) PrEP Guidelines are an updated adaptation of the 2014 US Centers for Disease Control's PrEP guidelines and are designed to: •Support the… CONTINUE READING
6 Citations
44 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

  • RD Cooper, N Wiebe, N Smith
  • AIDS
  • 2016

Prospective study of acute HIV - 1 infection in adults in East Africa and Thailand

  • JM Baeten, D Donnell, P Ndase
  • N Engl J Med
  • 2016

Similar Papers

Loading similar papers…